Breastfeeding is not recommended while on Semaglutide tablet
Food and Drug Administration Adverse Events Database, where the spontaneous reporting rates of pancreatic and thyroid cancers were 2.9 and 4.7 times higher, respectively, with exenatide compared with other oral antidiabetic drugs [10]
Yes, Semaglutide is commonly prescribed for managing type 2 diabetes
Patients should also consider the value of treatment outcomes rather than focusing on medication price alone
According to clinical studies, such as the STEP clinical trials, noticeable weight loss can be observed from about four weeks onward, with more significant results becoming evident within four to five months
This flexibility allows you to maintain your regular meal routine without needing to adjust for the medication